Patrick Nachman – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailpnachmanumnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

4 Active
8 Finished

8 results

Filter

Finished
Nephrotic Syndrome Rare Disease Clinical Research Network III ("NEPTUNE III")
Nachman, P. & Rheault, M. N.
UNIVERSITY OF MICHIGAN, NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
7/1/21 → 6/30/23
Project: Research project
United States Renal Data System (USRDS)
Nachman, P.
HENNEPIN HEALTHCARE RESEARCH INSTITUTE, NATIONAL INSTITUTES OF HEALTH (NIH)
6/8/19 → 1/2/20
Project: Research project
Multicenter, randomized, double-blind, placebo-controlled two stage study to characterize theefficacy, safety, tolerability and pharmacokinetics of GZ/SAR402671 in patients at risk of rapidlyprogressive Autosomal Dominant Polycystic Kidney Di
Nachman, P.
SANOFI-AVENTIS US
8/1/18 → 12/31/22
Project: Research project
CL012_140: A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safetyand Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS)
Nachman, P.
CHEMOCENTRYX, INC.
8/1/18 → 12/31/22
Project: Research project
AUR-VCS-2017-03: An Open-Label, Dose-Exploration Cohort Study Evaluating the Efficacy and Safety ofVoclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal SegmentalGlomerulosclerosis
Nachman, P.
AURINIA PHARMACEUTICALS, INC
6/1/18 → 12/31/21
Project: Research project
IFX-1-P2.6: A randomized, double-blind, placebo-controlled, multicenter, parallel-group Phase II study toinvestigate the safety and efficacy of two different dose regimens of IFX-1 as add-on to standard of care insubjects with granulomatosis with polya
Nachman, P.
INFLARX GMBH
6/1/18 → 12/31/21
Project: Research project
Immune Tolerance Network
Nachman, P.
BENAROYA RESEARCH INST AT VIRGINIA MASON, NIH Nat'l Inst of Allergy & Infect Dis
4/1/18 → 1/31/23
Project: Research project
CL011_140: A Randomized, Double-Blind, Placebo-Controlle
Nachman, P.
CHEMOCENTRYX, INC.
3/1/18 → 12/31/20
Project: Research project